Work

Integrated epigenetic and transcriptomic analysis reveals low CD83 on B cells linked to refractory anti-PLA2R-associated membranous nephropathy

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Anti-phospholipase A2 receptor (anti-PLA2R)-associated membranous nephropathy (MN) is a primary form of autoimmune glomerulonephritis causing nephrotic syndrome. MN can develop a refractory or relapsing clinical course, but biomarkers associated with poor prognosis remain poorly defined. Methods We performed single-nucleus RNA-sequencing (snRNA-seq) and ATAC-sequencing (snATAC-seq) of peripheral immune cells from five refractory/relapsing MN, six remission MN, twelve disease-control and seven healthy individuals (HCs), and GeoMx spatial transcriptomics of diagnostic kidney biopsies from eight refractory/relapsing MN, eight remission MN and eight HCs. Results B cells from refractory/relapsing MN showed significantly reduced CD83 expression. After re-clustering B cells according to CD83 expression, we found that the CD83-high B cells, characterized by upregulation of BACH2, FOXP1, and FOXO1 exhibited significantly lower CD83 expression in the refractory/relapsing MN. Regulatory T cells (Tregs) were also reduced in refractory/relapsing MN. Conversely, glomerular transcriptomes showed minimal differences between refractory/relapsing and remission MN. Conclusions Our findings suggest that CD83-high B cells and Tregs are potential biomarkers and therapeutic targets for refractory/relapsing MN.
Language: English
Subfield: Nephrology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7233853979
FWCI:
Cites: 34
Cited by:
Related to: 10
Parts: 1